FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023633699> ?p ?o ?g. }

• W2023633699 endingPage "513" @default.
• W2023633699 startingPage "505" @default.
• W2023633699 abstract "Background: Several studies have documented the nephroprotective effect of cilastatin co-administered with imipenem in subjects treated with cyclosporin A. However, no large clinical studies are available to confirm this observation. Here the quality of the evidence on cilastatin nephroprotection against cyclosporin-induced nephrotoxicity is evaluated.Methods: The results of all studies where cyclosporin was used alone or combined with imipenem/cilastatin (Tienam*) on the same clinical setting were systematically reviewed. Primary outcome was the reduction in serum creatinine concentration. Secondary outcome included development of acute renal failure. Medline was searched using three different retrieval systems (Pubmed, Silver Platter, Knowledge Finder) from January 1966 to February 2006. Attempts were made to contact authors of relevant studies to obtain additional data. Five clinical studies were found, including 125 patients under cyclosporin plus imipenem/cilastatin and 104 under cyclosporin alone.Results: Cyclosporin increased serum creatinine in all the studies. Average reduction of serum creatinine in cilastatin-treated versus untreated patients was ∆ = –0.53 mg/dL (95%CI: –0.90 to –0.17) (Z = 2.84, p = 0.004). Variability between studies was large (from ∆ = –0.21 to ∆ = –1.59 mg/dL) and heterogeneity pronounced (χ2 = 8.760, df = 4; p = 0.067). Meta-regression of serum creatinine reduction versus baseline serum creatinine explained 84% of this variability, by the variation in basal serum creatinine. When randomized and observational clinical studies were analyzed separately, conclusions were the same: serum creatinine in cilastatin treated patients was reduced by ∆ = –0.98 mg/dL (95%CI: –1.57 to –0.38) in randomized studies (Z = 3.213, p = 0.001) and ∆ = –0.32 mg/dL (95%CI: –0.63 to –0.01) in observational studies (Z = 2.013, p = 0.044). Odds Ratio for developing acute renal failure was 0.24 (95% CI: 0.11–0.53, p < 0.0001) on patients simultaneously treated with cyclosporin plus imipenem/cilastatin compared to patients treated with cyclosporin alone.Conclusions: Administration of cilastatin may reduce acute cyclosporin nephrotoxicity." @default.
• W2023633699 created "2016-06-24" @default.
• W2023633699 creator A5003638045 @default.
• W2023633699 creator A5022134735 @default.
• W2023633699 creator A5024000333 @default.
• W2023633699 creator A5030541395 @default.
• W2023633699 creator A5044114546 @default.
• W2023633699 creator A5074437152 @default.
• W2023633699 date "2007-01-29" @default.
• W2023633699 modified "2023-10-18" @default.
• W2023633699 title "Cilastatin protection against cyclosporin A-induced nephro­toxicity: clinical evidence" @default.
• W2023633699 cites W114962087 @default.
• W2023633699 cites W1964435302 @default.
• W2023633699 cites W1966953116 @default.
• W2023633699 cites W1973767560 @default.
• W2023633699 cites W1978463699 @default.
• W2023633699 cites W1991546041 @default.
• W2023633699 cites W1995662581 @default.
• W2023633699 cites W2011586167 @default.
• W2023633699 cites W2012548293 @default.
• W2023633699 cites W2040722704 @default.
• W2023633699 cites W2107328434 @default.
• W2023633699 cites W2137967400 @default.
• W2023633699 cites W2164059447 @default.
• W2023633699 cites W2172155928 @default.
• W2023633699 cites W2271077928 @default.
• W2023633699 cites W2332936309 @default.
• W2023633699 cites W4234566972 @default.
• W2023633699 cites W4242348239 @default.
• W2023633699 doi "https://doi.org/10.1185/030079906x167633" @default.
• W2023633699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17355732" @default.
• W2023633699 hasPublicationYear "2007" @default.
• W2023633699 type Work @default.
• W2023633699 sameAs 2023633699 @default.
• W2023633699 citedByCount "16" @default.
• W2023633699 countsByYear W20236336992012 @default.
• W2023633699 countsByYear W20236336992015 @default.
• W2023633699 countsByYear W20236336992017 @default.
• W2023633699 countsByYear W20236336992018 @default.
• W2023633699 countsByYear W20236336992019 @default.
• W2023633699 countsByYear W20236336992020 @default.
• W2023633699 countsByYear W20236336992021 @default.
• W2023633699 countsByYear W20236336992023 @default.
• W2023633699 crossrefType "journal-article" @default.
• W2023633699 hasAuthorship W2023633699A5003638045 @default.
• W2023633699 hasAuthorship W2023633699A5022134735 @default.
• W2023633699 hasAuthorship W2023633699A5024000333 @default.
• W2023633699 hasAuthorship W2023633699A5030541395 @default.
• W2023633699 hasAuthorship W2023633699A5044114546 @default.
• W2023633699 hasAuthorship W2023633699A5074437152 @default.
• W2023633699 hasConcept C126189478 @default.
• W2023633699 hasConcept C126322002 @default.
• W2023633699 hasConcept C126894567 @default.
• W2023633699 hasConcept C159641895 @default.
• W2023633699 hasConcept C2777437143 @default.
• W2023633699 hasConcept C2779631663 @default.
• W2023633699 hasConcept C2780306776 @default.
• W2023633699 hasConcept C29730261 @default.
• W2023633699 hasConcept C501593827 @default.
• W2023633699 hasConcept C71924100 @default.
• W2023633699 hasConcept C86803240 @default.
• W2023633699 hasConcept C89423630 @default.
• W2023633699 hasConcept C90924648 @default.
• W2023633699 hasConcept C94665300 @default.
• W2023633699 hasConceptScore W2023633699C126189478 @default.
• W2023633699 hasConceptScore W2023633699C126322002 @default.
• W2023633699 hasConceptScore W2023633699C126894567 @default.
• W2023633699 hasConceptScore W2023633699C159641895 @default.
• W2023633699 hasConceptScore W2023633699C2777437143 @default.
• W2023633699 hasConceptScore W2023633699C2779631663 @default.
• W2023633699 hasConceptScore W2023633699C2780306776 @default.
• W2023633699 hasConceptScore W2023633699C29730261 @default.
• W2023633699 hasConceptScore W2023633699C501593827 @default.
• W2023633699 hasConceptScore W2023633699C71924100 @default.
• W2023633699 hasConceptScore W2023633699C86803240 @default.
• W2023633699 hasConceptScore W2023633699C89423630 @default.
• W2023633699 hasConceptScore W2023633699C90924648 @default.
• W2023633699 hasConceptScore W2023633699C94665300 @default.
• W2023633699 hasIssue "3" @default.
• W2023633699 hasLocation W20236336991 @default.
• W2023633699 hasLocation W20236336992 @default.
• W2023633699 hasOpenAccess W2023633699 @default.
• W2023633699 hasPrimaryLocation W20236336991 @default.
• W2023633699 hasRelatedWork W2022616407 @default.
• W2023633699 hasRelatedWork W2063107464 @default.
• W2023633699 hasRelatedWork W2093874596 @default.
• W2023633699 hasRelatedWork W2137967400 @default.
• W2023633699 hasRelatedWork W2566477261 @default.
• W2023633699 hasRelatedWork W2613546412 @default.
• W2023633699 hasRelatedWork W2916118991 @default.
• W2023633699 hasRelatedWork W2945165860 @default.
• W2023633699 hasRelatedWork W3152378732 @default.
• W2023633699 hasRelatedWork W85206306 @default.
• W2023633699 hasVolume "23" @default.
• W2023633699 isParatext "false" @default.
• W2023633699 isRetracted "false" @default.
• W2023633699 magId "2023633699" @default.
• W2023633699 workType "article" @default.